Understanding medical device regulations in the Netherlands is essential for manufacturers, importers, authorised representatives and distributors seeking access to the Dutch and wider EU markets. The Netherlands follows EU MDR and IVDR directly but compliance doesn’t stop at CE marking. There are country-specific obligations that sit on top of the EU rules. Getting these right early makes the whole process considerably smoother.
This guide covers what matters most including device classification, CE marking, registration, quality management, import requirements and post-market surveillance helping manufacturers move through the process with clarity and confidence.
Regulatory Authorities for Medical Devices in Netherlands
The Health and Youth Care Inspectorate (IGJ) is the Netherlands’ supervisory authority for compliance. It functions under the Ministry of Health, Welfare and Sport. IGJ is responsible for monitoring and supervising compliance with medical device requirements, working alongside oversight counterparts in other EU member states.
But day-to-day registration paperwork doesn’t run through IGJ directly. That’s handled by CIBG Farmatec, a separate executive agency. It is responsible for managing the NOTIS notification database on the IGJ’s behalf.
People new to the Dutch market often use IGJ and Farmatec interchangeably, but they serve different roles. IGJ is responsible for supervision and enforcement, while Farmatec manages registrations and EUDAMED registration assessments.
Beyond Dutch borders, the European Commission oversees MDR/IVDR EU-wide. Responsibility for conformity assessments of higher-risk devices lies with Notified Bodies listed in the NANDO database.
Netherlands Medical Device Classification
Netherlands Medical Device Classification runs entirely on MDR Annex VIII.There is no separate Dutch device classification system. Devices fall into Class I, IIa, IIb, or III, based on invasiveness, duration of body contact and whether the device is active.
- Class I – Lowest risk, generally self-declared
- Class IIa – Low to Moderate risk, Notified Body required
- Class IIb – Moderate to Higher risk, Notified Body required
- Class III – Highest risk, Notified Body required
Class Is (sterile), Class Im (measuring), and Class Ir (reusable surgical instruments) are distinct Class I subtypes that require Notified Body involvement for the relevant aspects of conformity assessment. IVDs also follow their own four-tier system under IVDR, Class A through D.
Borderline cases are where classification becomes challenging. For example, a seemingly minor claim in the labeling, such as a measuring function, can change the applicable classification from Class I to Class Im, triggering Notified Body involvement.
Authorized Representative (AR) Requirements in Netherlands
Non-EU manufacturers are required to appoint an EU Authorised Representative before placing a device on the market. The AR can be based anywhere within the EU but many non-EU manufacturers choose to establish theirs in the Netherlands. The country’s strategic logistics position including the Port of Rotterdam and its well-organised regulatory environment make it a practical and popular choice.
An EU Authorised Representative does more than provide a local address. Under Article 11 of the MDR and IVDR, the AR must verify the Declaration of Conformity, make technical documentation available to regulators, cooperate with competent authorities and act on the manufacturer’s behalf.
A written mandate between the manufacturer and the AR is mandatory and must identify the devices or device families covered.
Medical Device Regulatory Guidelines in Netherlands
The Netherlands has two regulations that govern medical device compliance: MDR (Regulation (EU) 2017/745) and IVDR (Regulation (EU) 2017/746). In addition to these regulations, manufacturers also need to work with the MDCG guidance documents and harmonised standards for the correct application of the requirements in practice.
MDCG guidance is worth paying attention to even though it carries no legal force on its own. IGJ references it during inspections and Notified Bodies use it to frame their assessments so in practice it functions closer to a requirement than a suggestion.
Standards are maintained in the Netherlands through NEN the Netherlands Standardization Institute. ISO 13485 and other harmonized standards referenced in technical documentation should always be the current NEN-adopted versions. It’s a detail that gets overlooked when documentation is carried over from other markets or earlier submissions and it tends to surface at exactly the wrong moment.
Medical Device Registration Process in Netherlands
To register a medical device in the Netherlands, manufacturers must complete the applicable EU MDR or IVDR conformity assessment and fulfil the Netherlands-specific registration requirements. Below is the typical step-by-step registration process.
Step 1: Classify the Device
Start here, and get it right. Netherlands Medical Device Classification follows MDR Annex VIII rules which are based on intended use, duration of body contact, invasiveness and whether the device is active. Class I is lowest risk; Class III is highest. IVDs follow IVDR and run Class A through D. A wrong classification invalidates the conformity route you’ve chosen and everything built on it.
Step 2: Build Technical Documentation
Technical documentation follows MDR Annex II and III and must cover the device description, design and manufacturing information, a General Safety and Performance Requirements (GSPR) checklist, risk management file per ISO 14971 and a clinical or performance evaluation. This is the backbone of the submission. Everything IGJ or a Notified Body reviews traces back to this file.
The most common documentation problem we see is the internal inconsistency. The intended use described in the clinical evaluation doesn’t quite match what’s on the label, and the risk management file references a third version. Align these before you move forward.
Step 3: Engage a Notified Body (Where Required)
Class IIa, IIb, and III devices, plus sterile and measuring-function Class I devices, need a Notified Body conformity assessment. The Chosen Notified Body should be accredited under the NANDO database. Notified Body queues are long right now across Europe. So this step alone can run several months to over a year depending on device complexity. Manufacturers should plan accordingly.
Step 4: Sign the Declaration of Conformity and Apply CE Marking
Once the conformity route is satisfied, the Declaration of Conformity is signed and the CE mark is applied. For eligible Class I devices this is done through self-certification; for higher classes it follows Notified Body assessment.
The Declaration of Conformity must specify the name of the manufacturer, the device, the relevant regulation and where appropriate the Notified Body and its certificate number. In the Netherlands, CE Marking for medical devices means that the medical device fulfills all applicable EU requirements.
Step 5: Register in EUDAMED
EUDAMED (European Database on Medical Devices) registration is mandatory. Economic operators must register in order to obtain a Single Registration Number (SRN), which is necessary for obtaining a conformity assessment and for placing the device available on the market.
Step 6: National Notification Through Farmatec/NOTIS
This is the step foreign manufacturers most often miss. Class I devices, custom-made devices and IVDs of any class must be notified through the Dutch NOTIS system managed by Farmatec. Once a complete submission is in, processing runs up to 90 days. Incomplete submissions restart that clock.
Teams often submit NOTIS notification last, treating it as a formality after CE marking is done. That 90-day window only starts once everything is in order. But if the submission is incomplete then it can push market entry well beyond what was planned.
Step 7: Finalize Dutch-Language Labeling and IFU
Labels and Instructions for Use (IFU) must be in Dutch for devices placed on the Dutch market, alongside the UDI (Unique Device Identifier) and all MDR/IVDR-mandated symbols. Manufacturers must not leave this for after registration because translation and layout review take time and errors here can hold up market access.
Step 8: Place the Device on the Market and Begin PMS
Once the above steps are complete, the device can enter the Dutch market. Post-market surveillance must start immediately. The PMS plan should already be active, feeding complaint data, literature reviews and field feedback into your monitoring system from day one.
Required Documents for Medical Device Registration in Netherlands
The core technical documentation required under MDR Annexes II and III includes:
- Device description and specification
- Design and manufacturing information
- General Safety and Performance Requirements (GSPR) checklist
- Risk management documentation
- Clinical evaluation report (CER) for medical devices or a performance evaluation report (PER) for IVDs
- Post-market surveillance (PMS) documentation, where applicable
For national registration through Farmatec, manufacturers will also need the Declaration of Conformity, the CE certificate (where a Notified Body was involved) and company identification details.
Manufacturers must ensure the EU Declaration of Conformity includes the manufacturer’s details, the relevant regulation, the device identification and the authorised representative’s information, where applicable.
QMS Requirements for Medical Devices in Netherlands
For standard self-certified Class I devices ISO 13485 certification is generally not required, though Article 10 of MDR still requires manufacturers to maintain an appropriate quality management system.
For all other devices, it is required to maintain a quality management system (QMS) covering areas such as risk management, clinical evaluation, document control and post-market surveillance. The Netherlands does not impose additional QMS requirements beyond the MDR. During inspections, the IGJ reviews QMS implementation.
For all other device classes Article 10 sets out QMS obligations covering risk management, clinical evaluation, document control and post-market surveillance. The Netherlands does not add requirements beyond what MDR already mandates on this point. In practice though IGJ does review QMS implementation during inspections and gaps between documented procedures and what’s actually happening on the floor are a finding that comes up regularly.
Medical Device Labeling & IFU Requirements in Netherlands
Dutch-language labeling and IFUs are required for the Dutch market, under Article 1 of the Ministerial Decree. Standardized symbols may be used where permitted, provided they comply with the MDR/IVDR and relevant harmonized standards.
Mandatory label information includes:
- Manufacturer’s name and address.
- Authorised Representative’s details (where applicable).
- Device name or trade name.
- Information needed to identify the device and its contents.
- Lot number or serial number.
- UDI (where applicable).
- Expiry date or use-by date, where relevant.
- Sterile status and sterilization method, where applicable.
- Any special storage or handling conditions.
- Warnings, precautions, or limitations necessary for safe use.
- CE marking, together with the Notified Body identification number where required.
Registration Timelines for Medical Devices in Netherlands
Once a complete submission has been received, NOTIS registrations are processed within a maximum of 90 days.
Class I devices: Standard Class I devices can be placed on the market once the manufacturer has met the applicable MDR requirements and completed any required national registration.
Class Is, Class Im, Class Ir, Class IIa, IIb, and III devices: Timelines depend on the Notified Body’s conformity assessment and typically range from several months to more than a year.
Medical Device Registration Costs in Netherlands
There’s no single official fee schedule published by IGJ or Farmatec covering every cost component.
Class I self-certification involves internal documentation costs and possibly translation/labeling spend, with no Notified Body fee. Higher classes carry Notified Body assessment fees, which vary by device type and the specific NB manufacturers choose.
AR fees, if applicable, are a separate ongoing cost agreed contractually.
Import Requirements for Medical Devices in Netherlands
Importing medical devices into the Netherlands requires compliance with both Dutch customs procedures and the applicable EU medical device regulations.The customs clearance process is managed by Dutch Customs (Belastingdienst).
Importers have specific responsibilities under the MDR and IVDR. These include verifying the CE marking, ensuring compliance of the labeling and instructions for use and verifying that the manufacturer and the device are properly identified before the device is placed on the market. Where applicable, they must also confirm that the manufacturer has appointed an EU Authorised Representative.
Non-EU manufacturers must also ensure the device is placed on the market through an EU-based importer.
Although the Port of Rotterdam is a major entry point for medical devices, it offers logistical advantages rather than regulatory ones. Imported devices must still comply with all applicable MDR or IVDR requirements.
Post-Market Surveillance Requirements in Netherlands
Once a device is on the market in the Netherlands, the compliance work continues under a structured post-market surveillance (PMS) system required by MDR. The process begins with a Post-Market Surveillance Plan (PMSP). A documented strategy outlining what data you’ll collect, from which sources, and how often.
The reporting requirements then depend on the device classification. Manufacturers of Class I devices must prepare a Post-Market Surveillance Report (PMSR) in accordance with Article 85.
The reporting requirements become more extensive for higher-risk devices. Under Article 86, manufacturers of Class IIa, IIb, and III devices must prepare a Periodic Safety Update Report (PSUR). The report is updated every two years for Class IIa devices and every year for Class IIb and Class III devices. Class III and implantable device PSURs are also shared with the Notified Body through EUDAMED, where applicable. Class III and implantable devices require PSUR submission to the Notified Body and an SSCP validated by the Notified Body and published through EUDAMED.
Manufacturers may also need to conduct Post-Market Clinical Follow-up (PMCF) to collect real-world clinical data and support ongoing updates to the Clinical Evaluation Report (CER). In addition to routine post-market surveillance, manufacturers must report serious incidents and Field Safety Corrective Actions (FSCAs) to the competent authority within the applicable reporting deadlines. Trend reporting is also required when a statistically significant increase in non-serious incidents or expected undesirable side effects could affect the device’s benefit-risk profile.
Conclusion
Most delays in Netherlands medical device registration come down to the same handful of issues like wrong classification, weak AR setup, missed national registration or PMS documentation that exists on paper but doesn’t hold up in practice. None of these are complicated to fix when caught early.
With Artixio’s end-to-end medical device registration services, manufacturers can streamline market entry and stay compliant throughout the product lifecycle. Reach out to us at info@artixio.com for guidance tailored to your device and market entry goals.
FAQs
Q1. Is CE Marking for Medical Devices in the Netherlands enough on its own to sell the device?
No. CE marking under MDR/IVDR is necessary, but Dutch national registration through Farmatec/NOTIS and EUDAMED economic operator registration are separate, additional steps for certain device classes.
Q2. Does every device need a Notified Body?
No. Self-certified Class I devices without a measuring function or sterility claim generally don’t, but most other classes do.
Q3. What language must labeling and IFUs be in?
Dutch, alongside whatever symbols and identifiers MDR/IVDR mandate.
Q4. Can a non-EU manufacturer register directly with Farmatec?
Generally no. This is handled through an EU Authorized Representative established in the Netherlands or another member state.
